Orthopaedic implant use increases infection risk. Implant infection risk can be explained by the "race for the surface" concept, where there is competition between host-cell integration and bacterial colonisation. Although generally accepted, the temporal dynamics have not been elucidated in vivo. Using a bilateral intramedullary rat model, Staphylococcus aureus was injected into the tail vein either immediately after or 1, 3 and 7 d following implant placement. This allowed assessment of the temporal interplay between bacterial colonisation and host-cell adhesion by uncoupling implant placement and bacterial challenge. 2 weeks following inoculation, animals were anaesthetised, euthanised and implants and tissues harvested for bacterial enumeration. To assess host participation in implant protection, additional animals were not inoculated but euthanised at 1, 3 or 7 d and the host cells adhered to the implant were evaluated by flow cytometry and microscopy. As time between implant placement and bacterial challenge increased, infection rate and bioburden decreased. All implants had measurable bioburden when challenged at day 1, but only two implants had recoverable bacteria when inoculated 7 d after implant placement. This protection against infection corresponded to a shift in host cell population surrounding the implant. Initially, cells present were primarily non-differentiated stem cells, such as bone marrow mesenchymal stem cells, or immature haematopoietic cells. At day 7, there was a mature monocyte/macrophage population. The present study illustrated a direct relationship between host immune cell attachment and decrease in bacterial colonisation, providing guidance for antimicrobial release devices to protect orthopaedic implants against bacterial colonisation.
Introduction
Although often necessary for treatment, orthopaedic implant use increases the risk of infection (Zimmerli and Sendi, 2011) . Bacteria rapidly colonise the surface of implanted biomaterials, resulting in recalcitrant biofilm formation (Elek and Conen, 1957; Gristina, 1987; Mayberry-Carson et al., 1984) . A key to implant survival is for host-tissue integration to occur prior to bacterial attachment (Gristina, 1987; Gristina et al., 1988) . Host integration involves an intimate bond between host cells and the implant surface, which is promoted by the implant's biocompatibility and its encouragement for a normal immune response after implant placement. Persistence of an implantcentred infection can result in elongated hospital stay with subsequent surgeries, implant removal and exchange or even limb amputation (Zimmerli and Sendi, 2011) . A common anti-infective approach is to prevent bacterial attachment by surface modifications (Campoccia et al., 2013) . Techniques for preventing bacterial colonisation include modifications and surface coatings that can prevent attachment or eradicate local bacteria (Shiels et al., 2018a) . Unfortunately, the types of modifications that can be utilised are generally limited due to local tissue response, in situ coating degradation or antibioticrelease exhaustion (Campoccia et al., 2013) .
With more than 2,000 citations to the seminal article, the concept of "race for the surface" is widely accepted as the theory that best explains the competition between host and bacteria for implant colonisation (Gristina, 1987) . If the implant is colonised by bacteria first, recalcitrant bacterial biofilms form, contributing to device failure and further treatment (Costerton, 2005) . Conversely, host-tissue integration with the implant occurring before bacterial colonisation reduces the risk of SM Shiels et al. Pre-clinical assessment of the "race for the surface" infection, increases implant survival and improves patient recovery (Subbiahdoss et al., 2009) . Although this concept has been well elucidated using in vitro techniques, there are few in vivo experiments demonstrating the relationship between implant placement and bacterial colonisation (Busscher et al., 2012; Martinez-Perez et al., 2017; Subbiahdoss et al., 2011) . Rabbit models have been used to identify the likelihood of prosthetic infection using a haematogenous route of administration (Blomgren and Lindgren, 1981; Southwood et al., 1985) . Similarly, using a rodent model of haematogenous implant infection, the implant placement and bacterial challenge can be uncoupled in an effort to better understand the early time course relationship between host-cell attachment and bacterial colonisation. This information will provide valuable guidance to design effective strategies to reduce implant-related infections.
Materials and Methods

Experimental overview
To thoroughly investigate the temporal relationship between implant placement and exposure to bacteria, two experiments were performed. Part I uncoupled implant placement from the bacterial challenge, providing an insight on how long it takes for the host to protect the implant against bacterial colonisation. Part II determined the cell population on and immediately around the biomaterial at various time points after implantation to elucidate what host cells are potentially playing a protective role. Animal research was conducted in compliance with the Animal Welfare Act, the implementing Animal Welfare Regulations and the principles of the Guide for the Care and Use of Laboratory Animals, National Research Council. The Institutional Animal Care and Use Committee of the US Army Institute of Surgical Research approved all research conducted. The facility where the research was conducted is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
Animals were observed daily for at least the first 3 d after both surgery and bacterial inoculation for signs of pain and distress such as lethargy, lack of grooming, lack of mobility and weight loss. If there were indications of a failure to thrive, such as no response upon provocation or weight loss more than 20 %, the animal was immediately anaesthetised, euthanised and excluded from the study. If animals were found dead in their cage, they were excluded from the study.
Part I: evaluating bacterial colonisation UAMS-1 (ATCC49230), a wild-type parental strain of an osteomyelitis isolate of methicillin-susceptible Staphylococcus aureus (S. aureus) was used as pathogen (Gillaspy et al., 1995) . UAMS-1 is both clinically relevant and has been used extensively in orthopaedic research (An and Freidman, 1998; Ellington et al., 2006; Shiels et al., 2018b; Smeltzer et al., 1997) . This will be referred to as UAMS-1P. Although known reference strains and subtypes could have been used for the present study, reporter variants of UAMS-1P were investigated. Strain variations impact infection rate, biofilm formation and recalcitrance to infection (Jenkins et al., 2015; Recker et al., 2017) . Although fluorescent or luminescent reporter strains are commonly interchanged with parental strains to improve visualisation, measurement and reduce animal numbers, they, similarly to strain variations, have differences in virulence and biofilm-forming capacities as compared to their parental strain (Knodler et al., 2005; Margolin, 2000; Southward and Surette, 2002; Suff and Waddington, 2017) . Green fluorescent protein (GFP) UAMS-1 (UAMS-1GFP) contains a GFP plasmid introduced by phage transduction (acquired from the Dental Trauma Research Department of the U.S. Army Institute of Surgical Research) (Chen et al., 2012) . Luminescent UAMS-1 (UAMS-1LUM) contains a stable copy of the Photorhabdus luminescens lux operon on its bacterial chromosome (Xen40, PerkinElmer ). Previous unpublished experience with these reporters indicated differences in colonisation and virulence. To better understand host-cell attachment, bacterial colonisation relationship with regards to biofilm and virulence while minimising the differences between the bacteria, these modified UAM-1 pathogens were also included.
An in vivo model of haematogenous implant infection was used to evaluate the effect time has on implant colonisation of UAMS-1 (Shiels et al., 2015) . Titanium Kirschner wire implants (1.25 mm × 23 mm, Synthes), which are used to model intramedullary nails (IMNs), were inserted in a retrograde fashion in the intramedullary canal of both femora of anaesthetised male Sprague-Dawley rats (N = 72, 364 ± 1 g; n = 6/group) ( Fig. 1 ). Briefly, a medial incision was made through the skin and into the joint capsule. The patella was reflexed laterally, exposing the intercondylar notch. An 18G bevelled, cannulated needle was used to access and ream the intramedullary canal through the intercondylar notch. The IMN was pushed into the canal, flush with the tibial plateau and arthrotomy and skin were closed. Following surgical closure, animals were randomly separated into one of three bacteria groups (UAMS-1P, UAMS-1GFP or UAMS-1LUM) then into one of the four time-to-inoculation groups [immediately post-operatively or post-operative day (POD) 1, 3 or 7; Fig. 1 ]. Bacteria [1.3 × 10 7 ± 5.2 × 10 5 colony forming units (CFU)/300 µL] were previously prepared in tryptic soy broth (TSB, Thermo Fisher Scientific) and frozen during log-phase growth. On the day of surgery, the bacteria were thawed, washed, suspended in saline and injected into the tail vein. 2 weeks following inoculation, animals were anaesthetised, euthanised with an overdose of sodium pentobarbital and hind limbs were www.ecmjournal.org aseptically harvested. Samples were processed for bacterial enumeration. IMNs were placed into sterile saline and sonicated to remove attached bacteria. Femora were snap-frozen, pulverised to a fine powder, resuspended in sterile saline and vortexed to collect bacteria. Serial dilutions of IMN and bone supernatants were plated on to sheep's blood agar and incubated overnight. CFU were counted and normalised to sample weight.
Bacterial growth: in vitro
To measure growth rate in vitro, the three variations of UAMS-1 were grown in TSB overnight. Dilutions of optical density 0.05, as measured at 600 nm (OD600), were prepared from the overnight cultures in TSB and grown at 37 °C. Optical density measurements were taken over a 24 h period to measure the change in absorbance and, thus, in bacteria number. Three samples per bacteria variation were prepared and measured.
Bacterial biofilm production: in vitro UAMS-1P, UAMS-1GFP and UAMS-1LUM were grown in TSB at 37 °C to OD600 0.12. Glass chamber slides were prepared by precoating each well with 10 % human serum. Bacteria in TSB were added to each well and incubated for 24 h at 37 °C to form a biofilm. Subsequently, bacterial biofilms were stained with Filmtracer LIVE/DEAD biofilm viability stain (Invitrogen). Images were acquired with a 488 nm laser using the Fluoview 1000 (Olympus) confocal laser scanning microscope at 20× magnification. Biomass and biofilm thickness were calculated by Comstat 2 analysis software (Heydorn et al., 2000; Vorregaard M (2008) Comstat2-a modern 3D image analysis environment for biofilms. Technical University of Denmark, Lyngby, Denmark.) using 2D Z-stack imaging of 4.17 μm-thick sections to prepare 3D biofilm structures from the different biofilms. One biofilm per variation was prepared and 10 random measurements acquired per biofilm.
Transcription of bacterial virulence and biofilm genes: in vitro
To determine the role of virulence in the risk of infection, RNA was recovered and analysed using real-time PCR from UAMS-1P, UAMS-1GFP and UAMS-1LUM. First, bacteria were grown to OD600 
Gene
Sequence Description agrA F AAC TGC ACA TAC ACG CTT ACA Required for high-level post-exponential phase expression of a series of secreted proteins. Involved in virulence potential (Traber et al., 2008) . R GGC AAT GAG TCT GTG AGA TTT (Kalinka et al., 2014) icaA F CTT GCT GGC GCA GTC AAT AC A member of a gene series that encodes proteins mediating the synthesis of polysaccharide intercellular adhesion and polysaccharide/adhesion in staphylococci species for biofilm formation (Yazdani et al., 2006) .
R
GTA GCC AAC GTC GAC AAC TG (Iqbal et al., 2016) rnaIII F AAT TAG CAA GTG AGT AAC ATT TGC TAG T Known to regulate the expression of many S. aureus genes encoding exoproteins and cell-wall-associated proteins. In S. aureus, RNAIII acts as the effector of the agr quorum sensing system and is transcribed from the P3 operon (Traber et al., 2008) . RNAIII also encodes for the toxin deltahemolysin (Verdon et al., 2009) . et al., 2014) sarA F GTA ATG AGC ATG ATG AAA GAA CTG T Global regulator, with both positive and negative effects, that controls the expression of several virulence factors and the biofilm formation process in a celldensity-dependent manner. Required for transcription of the primary transcripts RNAII and RNAIII generated by agr locus.
Negatively regulates the expression of spa (protein A) and aur (metalloprotease aureolysin) (Valle et al., 2003) . 0.25 in three conditions: TSB medium at 37 °C, TSB medium plus 10 % human serum at 37 °C and TSB medium at 37 °C then frozen at − 80 °C. Bacteria were collected by centrifugation, resuspended in RNAprotect (Qiagen) and incubated for 10 min at room temperature. Cells were collected by centrifugation, resuspended in lysing reagent (1 mg/ mL lysostaphin, 1000 U/μL lysozyme and 600 mU/ mL Proteinase K), vortexed and incubated for 15 min at 37 °C with intermittent vortexing. Following incubation, Buffer RLT (Qiagen) substituted with β-mercaptoethanol was added to the lysing bacteria, transferred to a tube with 0.5 mm glass beads and homogenised (Bead Ruptor Elite, Omni International, Kennesaw, GA, USA). RNA was collected from the lysed bacteria cells using the EZ1 (Qiagen) and, after concentration was determined (Nanodrop, Thermo Fisher Scientific) and integrity checked (TapeStation, Agilent) (Busscher et al., 2012) , frozen. Genomic DNA, cDNA and real-time PCR were prepared according to the RT2 qPCR Primer Assay Handbook using the RT2 SYBER Green Mastermix and the CFX 96 Thermocycler (Biorad). Genes of interest were agrA, icaA, rnaiii and sarA (Table 1 ) (Iqbal et al., 2016; Kalinka et al., 2014; Sully et al., 2014; Traber et al., 2008; Valle et al., 2003; Verdon et al., 2009; Yazdani et al., 2006) . One stock of each bacterial strain was prepared and RNA recovered. Three replicates of each stock were processed for RT2 qPCR.
Part II: quantitative analysis of host-cell-implant interaction
The "race for the surface" involves bacteria competing against host cells. A model mimicking the infection study was chosen to identify the cellular host components involved in implant integration prior to a bacterial challenge. Similarly to part I, IMNs were inserted in femora of anaesthetised Sprague Dawley rats (N = 18, male, 425 ± 9 g; n = 6 animals/group; 3 limbs/outcome measure) as previously described.
Following surgical closure, animals were randomly assigned to one of three time-point groups, POD 1, 3 or 7 ( Fig. 1 ). On the day of tissue collection, animals were anaesthetised, euthanised with an overdose of pentobarbital and hind limbs aseptically harvested.
The host-cell population on the IMN and within the bone marrow (BM) was evaluated by flow cytometry, histology and scanning electron microscopy (SEM).
Fig. 1.
Complete study design and workflow of part I and part II. Part I assessed bacterial colonisation of the implants by bacteria from a haematogenous source. Animals received implants on day 0 (black). After being separated into groups, animals were injected through tail vein with S. aureus either immediately postoperative or 1, 3 and 7 d later (grey). 14 d after inoculation, animals were anaesthetised, euthanised and implants and tissues harvested for quantitative enumeration (diamonds). Part II assessed host-cell integration of titanium implants using the same time-point used in part I. Animals received implants on day 0 (black).
After being separated into groups, animals were anaesthetised, euthanised and implants harvested 1, 3 or 7 d later (diamonds). Implants and tissues were processed for flow cytometry, histology or SEM. www.ecmjournal.org
Flow cytometry
At the time of euthanasia, femora were disarticulated, freed from soft-tissue and the proximal third removed with sterile rongeurs. IMNs were removed aseptically and placed into sterile 5 mL flow cytometry tubes containing pre-warmed 0.05 % trypsin-ethylenediaminetetraacetic acid (EDTA) (Life Technologies) and incubated for 3-5 min with gentle warming to detach adherent cells. Next, 10× volumes of sterile, low-endotoxin, 10 % foetal bovine serum (FBS, Gibco) solution prepared in sterile phosphatebuffered saline (PBS; Life Technologies) was added to inactivate the trypsin, then stored on ice. Following removal of the IMN, the femoral canal was flushed using sterile fluorescence-activated cell sorting (FACS)-PBS (Sterile Milentyi AutoMACS Rinsing solution) containing 1 % bovine serum albumin (BSA, Miltenyi Biotec), to collect BM cells.
Following inactivation of trypsin-EDTA with 10 % FBS, IMNs were removed from the tube and placed on a 100 μm cell strainer. Each wire was rinsed with sterile, ice-cold FACS-PBS to remove any weakly attached cells. Following the initial rinse, K-wires were discarded and the remaining cell suspension was filtered through the same 100 μm cell strainers. Bone marrow samples were agitated by pipetting to dissociate aggregates, then filtered using 100 μm cell strainers. Cell suspensions were centrifuged at 400 ×g for 5 min at 4 °C and the resulting pellets were treated with 1× red blood cell lysis buffer (Biolegend, San Diego, CA, USA) according to manufacturer's directions. Cell pellets were resuspended and viable cells counted using trypan blue staining solution on a haemocytometer.
Cells were stained with the antibodies CD45-BV510 (Clone: OX-1BD; OptiBuild, San Jose, CA, USA), CD11b-FITC (Clone: OX-42; BD Pharmingen, BD Biosciences), CD90-APC/Cy7 (Clone: OX-7; Biolegend) and CD68-Dylight ® 405 (Clone: ED1; Novus Biologicals, Littleton, CO, USA). Briefly, cells from both the K-wire (IMN) and the BM were washed with FACS-PBS and incubated with Fcblock (BD Pharmingen) to prevent non-specific binding. Then, cells were stained in FACS-PBS with surface marker antigens CD11b, CD90 and CD45 for 30 min at 4 °C in the dark. Cells were washed twice, then prepared for intracellular staining using a commercially available buffer set according to the manufacturer's instructions (eBioscience Intracellular Fixation & Permeabilization Buffer Set, Thermo Fisher Scientific). Briefly, cells were fixed with fixation buffer for 30 min at room temperature, then washed twice with permeabilisation buffer. Cells were stained with CD68 in permeabilisation buffer for 30 min at room temperature in the dark, washed twice, then resuspended in 500 µL FACS-PBS prior to analysis using a multi-parameter flow cytometer (FACSMelody, BD Biosciences). Flow cytometric compensation was performed using fluorescent compensation beads (BD Ultracomp, BD Biosciences).
Cellular attachment to the implant surface, as well as changes to inflammatory cell populations in the BM were assessed by FACS at PODs 1, 3 and 7. A gating strategy to remove debris and cells with
Fig. 2. A broad gating strategy was used to include both high and low SSC populations to include most
of the cells in the stromal fraction. Then, cells were gated and analysed based on CD45 + or CD45 − staining.
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higher forward and side scatter, followed by double discrimination, was used to analyse singlet cells (Fig.  2) . Cells were separated based on CD45 staining, a pan-haematopoietic marker, then analysed for surface marker expression of CD90, found on stem cells and fibroblasts, or CD11b, which is a monocyte and macrophage marker. CD45 − and CD11b + cells were further assessed for intracellular expression of CD68, a lysosomal marker that is highly enriched in macrophages but has also been documented in human fibroblasts (Gottfried et al., 2008) .
Histology
Following euthanasia, femora were disarticulated, freed from tissue, the proximal third removed and submerged in 10 % phosphate-buffered formalin for 2 weeks without removal of the IMN. Femora were processed for plastic-embedded histology by dehydration in graded ethanol series, clearing in xylene and embedding with polymethylmethacrylate (Tecnovit 1720, Exakt Technologies, Oklahoma City, OK, USA). Cross sections were prepared through the proximal epiphysis and mid-diaphysis by watercooled band saw (Exakt Technologies), ground and polished to 30 μm thickness. Sections were stained with toluidine blue and basic fuchsin and reviewed for cellular content adjacent to the implant using brightfield microscopy at 100×.
SEM
IMNs were recovered from femora and placed into 3 % glutaraldehyde (Electron Microscopy Sciences,
Hatfield, PA, USA) in phosphate buffer (pH 7.4) for 2 h. After 2 h, IMNs were rinsed three times with phosphate buffer followed by serial dehydration steps from 50 to 100 % ethanol. After the final 100 % ethanol step, IMNs were dried for SEM by first placing them in 50 % hexamethydisilazane (HMDS) in ethanol followed by 100 % HMDS. K-wires were left to air dry before storage at room temperature. IMNs were sputter-coated with gold and carbon and imaged on a Zeiss Sigma VP scanning electron microscope.
Data analysis
Data are represented as mean ± standard error of the mean and analysed using ANOVA with an alpha of 0.05, unless otherwise stated. Flow cytometry data are represented as mean ± standard deviation (SD). Infection rate and mortality rate are represented as fraction of the sample or group, respectively. A Fisher's exact test was used to detect differences among the infection rate. GraphPad's Prism and QuickCalcs (GraphPad Software) were used to run these analyses. A linear mixed model was used to analyse the log 10 (CFU) measured in bone tissue and on the IMN. In each regression model, inoculation day, strain and interaction of these two factors were used as fixed explanatory variables. Animal leg was included as a random effect in the model to account for samples being collected from both femora of each animal. The best fitting residual covariance structure for each outcome was determined using Akaike information criterion (AIC) and Bayesian information Greek letters are comparison of groups within each time. Horizontal line represents group median. Groups that do not share the same Latin letter within each group are different across time (p < 0.05). Time points that do not share the same Greek letter are different across groups (p < 0.05). (c) Infection rate for total number of limbs that completed the study. Animals that did not complete the study were excluded. Infection rate was determined based on the presence of more than 10 3 bacteria in either bone or IMN. Kramer) . The linear mixed model was performed using SAS 9.4 (SAS Institute, Cary, NC, USA) and significance was evaluated using an alpha of 0.05.
Day of inoculation
Results
Delaying bacterial challenge resulted in less colonisation on the IMN Post-operative time to bacterial challenge played a significant role in the amount of bioburden and rate of infection. As the time between implant placement and bacterial inoculation increased, the colonisation of the IMN decreased ( Fig. 3a) . When injected immediately after implant placement, the wires were heavily colonised by bacteria. None of the UAMS-1LUM animals inoculated at the time of surgery survived until the end of the study period; two were found dead in their cage and four were euthanised due to failure to thrive. When UAMS-1P and UAMS-1LUM were injected 7 d after surgery, only one wire from each group had recoverable bacteria, 8.5 × 10 2 and 1.2 × 10 6 CFU, respectively.
With increased time to inoculation, the UAMS-1GFP bioburden on the implant quickly diminished, falling from 8.2 × 10 5 ± 3.0 × 10 5 , when inoculated at the time of surgery, to 5.8 × 10 4 ± 5.8 × 10 4 by POD 3. No bacteria were recovered when inoculated at POD 7. A similar decreasing trend was identified in the bone tissue (Fig. 3b) . While UAMS-1P and UAMS-1LUM bone samples were both still infected in 4 of 8 limbs when injected at POD 7, the number of bacteria decreased from when the animals were inoculated 1 d after surgery. Additionally, UAMS-1GFP had no recoverable bacteria from the bone tissue when injected at POD 7. Infection rates decreased as time between incident surgery and bacteria inoculation increased (Fig. 3c ). Infection was defined quantitatively when samples contained > 10 3 CFU/g sample. Infection was supported by gross findings (i.e. purulence, osteolysis) and radiographic indications (reactive bone formation, lucency and cortical thinning). Radiographs acquired at the end of the study supported the quantitative microbiology, revealing severe osteolytic bone, reactive bone formation and lucent bone tissue (Fig. 4) . When inoculated at the time of surgery, all groups contained animals that presented with osteolysis around the implantation site and knee. As time from implant placement to inoculation increased, those animals inoculated with UAMS-1GFP presented decreasing radiographic Animal weight change and mortality was indicative of general animal health and supported the quantitative microbiology. Those animals that received UAMS-1GFP survived the length of the study and were able to regain preoperative weight when inoculated 7 d post surgery (Fig. 5) . None of the animals that received UAMS-1P or UAM-1LUM recovered to preoperative weight. As previously mentioned, there was a 6/6 mortality rate of the animals inoculated with UAMS-1LUM when injected at the time of surgery due to failure to thrive. Although survival rate slightly improved as bacterial challenge was delayed, there continued to be deaths within the UAMS-1P and UAMS-1LUM groups whereas the mortality rate for the UAMS-1GFP group was zero (Fig. 5) . A board-certified veterinary pathologist determined that septicaemia and shock were the cause of death for several animals, grossly indicated by the rapid weight loss and kidney lesions. Implant-associated findings were not determined from these animals and they were excluded from the study.
Considering the differences observed when animals were inoculated with different reporters, further characterisation into each reporter strain was performed. Using optical density, it was revealed that UAMS-1GFP grew slower than both UAMS-1P and UAMS-1LUM in TSB, which could have implications in vivo. Over the first 8 h, UAMS-1GFP had a growth rate of 0.060/h whereas UAMS-1P and UAMS-1LUM had growth rates of 0.092/h and 0.086/h, respectively (Fig. 6 ). However, by 24 h, UAMS-1GFP had lower growth rate than the UAMS-1P parental strain. When bacterial biofilm formation was evaluated for bioburden, thickness and biomass, there were visual differences in biofilm appearance, with UAMS-1P forming a more uniform biofilm as compared to UAMS-1GFP and UAMS-1LUM, which showed patches of low growth (Fig. 7) . Nevertheless, there were no differences in average CFU, biofilm thickness or living biomass, a measurement of the amount of # represents significance between groups within each time-point (p < 0.05), t-test (day 0) or ANOVA (day 1, 3 or 7). There was significant difference in mortality rate between UAMS-1GFP and UAMS-1LUM groups at day 0 inoculation time (p < 0.01; Fisher's exact test).
Fig. 6. Bacteria growth curve.
There was a significant difference in the growth of UAMS-1GFP as compared to UAMS-1P between 3 and 24 h at each of the measured time points. There was no difference between UAMS-1LUM and UAMS-1P during the growth period except at the 6 h measurement. www.ecmjournal.org Fig. 7 . Bacterial biofilm formation. There were visual differences in biofilm formation between UAMS-1P, UAMS-1GFP and UAMS-1LUM. UAMS-1P grew in a uniform lawn whereas both UAMS-1GFP and UAMS-1LUM had patches of no growth. While there were no differences in live biomass (p = 0.63; Kruskal-Wallis), dead biomass of UAMS-1GFP was significantly different from that of UAMS-1P (* p < 0.05).
biological material present in a given area, among the three bacteria types (Fig. 7) . Compared to the parental UAMS-1P type, UAMS-1GFP and UAMS-1LUM expressed different patterns of the important virulence regulator agrA and biofilm-associated locus, icaA. While UAMS-1GFP had reduced agrA expression, its icaA expression was 5.4-fold upregulated (Fig. 8) . Strangely, icaA and sarA loci were down-regulated in the UAMS-1GFP when the samples were frozen. Considering their importance in biofilm formation, this may explain the reduced biofilm formation in vivo. In contrast, UAMS-1LUM expressed 5.3-fold upregulated virulence regulator agrA in all preparation conditions. Understandably, the presence of soluble host factors, quorum sensing and biofilm formation will alter these expressions. These expressions provided a representation of the genetic differences among these reporter strains and some explanation for the mortality rate differences detected during the animal study.
Host-cell interaction with the implant changes over time
A flow cytometry protocol was developed to isolate and analyse the cellular populations that were adherent to the IMN and within the BM at 1, 3 and 7 d post implantation (Fig. 9 ). The gating strategy implemented was meant to include most of the cells in the stromal fraction (Fig. 2) while minimising doublets, potential debris and cells with very high scatter properties. Then, cells were gated and analysed based on CD45 + or CD45 − staining. Further gating was used to assess cells of monocytic (CD45 + / CD11B + /CD68 + ) or potential mesenchymal lineage (CD45 − /CD90 + ). While not well described in rats, some authors have described a CD45 − /CD68 + population of human primary fibroblasts that brightly stain for CD68 + (Gottfried et al., 2008) ; this population was assessed as well. 1 d following implantation, approximately 44 % of all CD45 − cells on the IMN surface appeared to be of a mesenchymal or fibroblast lineage, exhibiting a CD45 − /CD90 + phenotype (Table  2) . While the percentage of CD45 − cells did not decrease over time, the number of CD45 − /CD90 + cells dropped drastically over the course of 7 d. CD45 − / CD68 + cells were transiently increased on the IMN surface at day 3, but this population dropped off by day 7. Conversely, few cells exhibited a monocytic/ macrophage phenotype early after implantation of the IMN. At day 1, only 12 % of the CD45 + population co-expressed CD11b and CD68. This percentage increased to approximately one third of all CD45 + cells by day 7. During this time course, the percentage of CD45 + cells did not change dramatically. In the bone marrow, the percentage of CD45 − /CD90 + did not vary widely over the course of the experiment. However, the percentage of monocyte/macrophage cells within the CD45 + population increased on day 3 and 7. In comparison to the IMN, populations of CD45 − /CD68 + fibroblasts in BM increased at day 3 and remained elevated at day 7.
Histological sections stained with toluidine blue and basic fuchsin supported the cytometric findings ( Fig. 10) . At day 1, small cells were trapped in a fibrous matrix adjacent to the implant. After 3 d, the separation between haematopoietic and SM Shiels et al.
Pre-clinical assessment of the "race for the surface" non-haematopoietic cells became visible with the appearance of macrophages and spindle cells. At day 7, there were foreign body giant cell formation, a fusion of macrophages that were indistinguishable with the flow cytometry stains used. SEM images of the IMN recovered from the bones corroborated the host-cell change on the surface (Fig.  11) . When recovered early, after day 1, the IMNs were consistently covered in erythrocytes and spindle cells. As time progressed, the cell population on the IMN shifted to larger macrophage and monocyte-like cells.
Discussion
By uncoupling the initial implant placement from the bacterial challenge, the IMN's susceptibility to bacterial colonisation was determined and linked to the host adhesion in an immunocompetent rat model. When time increased between initial implant placement and S. aureus inoculation, the risk of infection decreased. All implants were highly colonised when the bacterial challenge was immediate or 1 d after implantation. 3 d following surgery there was a reduced number of bacteria on the implants. After 7 d in situ, the IMNs were not colonised by bacteria. These reductions in the number of colonising bacteria coincided with an increasing number of differentiated immune cells present on the implant. A protective layer of CD45 + /CD68 + monocytes and macrophages was first identified on the IMN 3 d after implantation. Although at this time only half of the haematopoietic cells differentiated into macrophages and monocytes on the implant, they were able to thwart colonisation by UAMS-1GFP, the least virulent strain used in the study. The number of these immune cells increased at day 7, which allowed for almost complete thwarting of bacterial colonisation of the implants in every group. To the authors' knowledge, this is the first preclinical evidence for temporal haematopoietic differentiation directly on the surface of an orthopaedic implant with a correlating reduction in implant infection.
The stromal fraction present on the orthopaedic implant contained both non-haematopoietic (CD45 − ) and haematopoietic (CD45 + ) populations. Initially, a sizable proportion of the non-haematopoietic population on the implant surface co-expressed CD90, indicating many of these cells were of a spindle-cell (fibroblast or stem cell) phenotype. Throughout the course of the experiment, the proportion of CD45 − /CD90 + cells present on the IMN decreased. CD90 expression plays an important role in the maintenance of an undifferentiated state in MSCs and the loss of this cell marker on the IMN surface indicated that these cells received signals for terminal differentiation (Moraes et al., 2016) . While the tracking of these stem cell populations maturing into immune cells was beyond the scope of the study, Hotchkiss et al. (2019) , using human MSCs cultured on implant surfaces, discovered an upregulation of osteoblast differentiation markers at 3 and 7 d post cell attachment. As such, it is not unreasonable to assume that the loss of CD90 + cell populations in the present study was due to differentiation of adherent cells. In addition to the non-haematopoietic cells, haematopoietic lineage cells were present on the surface of the implant at day 1, although this population did not co-express the monocyte/macrophage surface marker CD68 at this early time point. In contrast to the loss of CD90 + populations over the course of the study, the number of haematopoietic populations co-expressing the monocyte/macrophage marker CD68 drastically increased over time. This finding is supported by recent kinetic analysis of cellular colonisation on both alginate spheres and polypropylene mesh.
Fig. 9. Effect of time on both IMN surface adherent cells and cells found in bone marrow (BM).
Flow cytometry for cells recovered from (a) IMN and (b) BM. CD45 identifies a haematopoietic cell lineage. CD11b and CD68 identify a monocytic/macrophagic lineage among CD45 + parent population. CD90 identifies stem cell and fibroblast cells among CD45 − parent population. Total populations were 25,000 cells for BM and 7,000 cells for IMN.
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Pre-clinical assessment of the "race for the surface" BM after 1, 3 and 7 d in situ. CD45 identifies a haematopoietic cell lineage. CD11b and CD68 identify a monocytic/macrophagic lineage among CD45 + parent population. CD90 identifies stem cell and fibroblast cells among CD45 − parent population. Total populations were 25,00 cells for BM and 7,000 cells for IMN. Percentage total population are percentage of stained cells among total cells recovered from either IMN or BM ± SD. ND: not determined. Veish et al. (2015) revealed myeloid cells (CD11b + ) to predominate the surface of alginate beads at day 1 and CD68 + cells increasing until plateauing at 7 d post subcutaneous implantation. Similarly, polypropylene mesh induces a robust recruitment and differentiation of myeloid cells 7 d after subcutaneous implantation (Heymann et al., 2019) . Furthermore, the eventual accumulation of monocytic cells on titanium surfaces corroborates with previous evidence for multinucleated foreign body giant cells (FBGC) on titanium surfaces following 5-7 d in rabbit cortical bone, as multinucleated giant cells form from the fusion of macrophages (Gottlow et al., 2010; Sennerby et al., 1993) . It should be noted that the increase in CD68 + and decrease in CD90 + populations in the present study were not accompanied by changes to the ratio of haematopoietic and non-haematopoietic cells within the total cell population on the implant surface. This finding indicated that cellular colonisation of the implant is an active process and that the maturing immune cell population may be present early after implantation but may require sufficient time to adopt a mature macrophage phenotype and provide protection to the implant surface. As such, alterations to cellular populations are compelling and may provide a mechanistic explanation for the reduction in bacterial colonisation of the implant seen by day 3 and 7. It has long been known that a foreign body potentiates an infection (Elek and Conen, 1957) . Implant infection likelihood, proposed by Gristina's original "race for the surface", is a widely accepted explanation for implant fate by suggesting a direct competition between host cells and bacteria to colonise the surface (Gristina, 1987; Gristina et al., 1988) . If the host cells integrate before the bacteria colonises it, the implant is protected, while bacterial adhesion to the implant surface is associated with an increased risk of infection. Since the introduction of the "race for the surface", multiple studies have investigated this theory. In vitro studies have demonstrated that the presence of bacteria or bacterial components on an implant surface greatly reduces the number of attaching osteoblastic cells and vice versa (Chu et al., 2018; Fernández et al., 2011; Lee et al., 2010; Martinez-Perez et al., 2017; Subbiahdoss et al., 2009; Yue et al., 2014) , while multiple investigators have identified time as a protective factor against haematogenous infection. Using a rabbit model of hip arthroplasty and a model of subcutaneous disc implantation, these studies indicated that significant protection against bacterial contamination can be conferred by increasing the time from implantation to inoculation (Gottenbos et al., 2001; Southwood et al., 1985) . These studies, however, did not investigate the role of host attachment to implanted materials in the likelihood of infection. While these studies provided valuable insight towards the understanding of competitive colonisation by host and bacteria, in vitro work does not reflect in vivo observations of host cell colonisation nor can it account for the role of blood components and deposition of an extracellular matrix on the implant surface. Early discoveries indicate that, rather than early colonisation by osteoblasts, the surface of a titanium implant is immediately coated with a thin layer of plasma components, followed by rapid platelet adhesion and macrophage colonisation (Sennerby et al., 1993) . Adherent macrophages initiate a foreign body response and undergo fusion soon after colonisation, resulting in the formation of FBGCs on the implant surface (Mariani et al., 2019; Sennerby et al., 1993) . Similarly, subcutaneous implants elicit a foreign body immune response in a time-dependent manner, with cells of the monocyte and macrophage lineage occupying the surface and fusing to initiate the foreign body response (Higgins et al., 2009) . The present study confirmed that haematopoietic cells are a key player, alongside other cell types, in initial early implant integration. However, to the authors' knowledge, there is only one in vitro study that involves macrophages in their "race" model (Subbiahdoss et al., 2011) . This initial macrophage response, originally thought to impede integration and promote bacterial colonisation, is crucial for early implant protection (Anderson et al., 2008; Gristina et al., 1991) . www.ecmjournal.org
The inflammatory microenvironment around an implant dictates the initiation of normal wound healing and, ideally, allows for rapid colonisation by stromal cells and appropriate immune cell populations (Anderson et al., 2008) . Under ideal conditions, an initial, short-lived inflammatory response protects the implant surface against bacterial colonisation while allowing for attachment and differentiation of fibroblasts and MSCs. In the present study, haematopoietic cells colonised the implant surface rapidly after implantation and quickly differentiated into immune cells of monocytic and macrophage lineage. Not only are these macrophage cells critical to initial protection of the implant against bacterial colonisation, but previous research indicates their necessity for colonisation by stem cell populations (Hotchkiss et al., 2018) . In vitro experiments indicate that macrophage polarisation does not appear to influence initial stem cell attachment; however, a predominantly pro-inflammatory macrophage phenotype may adversely affect stem cell spreading and proliferation (Wang et al., 2018) . While it is understood that polarisation towards a pro-inflammatory phenotype would be protective against bacterial colonisation, as this phenotype has a high phagocytic and bactericidal potential, studies have also indicated that a pro-inflammatory microenvironment may be less permissive for initiation of a FBGC response (Anderson et al., 2008; Galvan-Pena and O'Neill, 2014) . In the present study, it was not possible to quantify FBGCs by flow cytometry but they were identified on the IMN by histology at day 7. While the immune response varies by material and surface coating, titanium, in particular, fosters a rapid shift towards a more anti-inflammatory phenotype and, in the presence of anti-inflammatory cytokines, the rate of FBGC formation increases (Amengual-Penafiel et al., 2019; Anderson et al., 2008; Trindade et al., 2018) . The role FBGCs plays in implant protection or potential degradation is under debate . Unlimited FBGC activation can lead to implant encapsulation, aseptic loosening and attraction for bacteria ten Harkel et al., 2015 , Mariani 2019 Trindade et al., 2016) . Little research has been done to characterise Pre-clinical assessment of the "race for the surface" the specific FBGC response in the setting of bacterial infection but it is likely that, given the nature of their fusion and formation, these cells can respond to polarisation stimuli. While FBGCs generally do not represent a first line of defence against pathogen colonisation, early induction of FBGC formation and assumption of an anti-inflammatory phenotype could impede attachment of bacteria . Although identifying the polarisation of the attached macrophages, subsequent FBGC formation and long-term fate of the implant was outside the scope of the study, the appropriate ratio of proand anti-inflammatory macrophages starts proper host attachment and promotes implant fortification (Trindade et al., 2018) . As such, alterations to the implant surface to promote recruitment of any specific cell type should be considered carefully in order to promote proper early cellular attachment and limit changes to the normal inflammatory environment and progression of cellular colonisation and integration (Alfarsi et al., 2014) .
Medical device research has focused on surface modifications to combat implant bacterial colonisation by either preventing bacterial attachment or encouraging quicker tissue integration of the implant (Campoccia et al., 2013) . Host-cells are more selective than bacteria: their discriminating attachment, slower motility and protracted proliferation contribute to a slower rate of integration. Modifications to the implant surface must initiate the appropriate host response while deterring a prolonged foreign body reaction that would potentiate continued dysregulation of the local immune response and prolong the implant's susceptibility to bacterial colonisation. Therefore, antimicrobial surface coatings represent a reasonable solution. There are currently two devices approved for use in high-risk patients in Europe that provide a protective surface to thwart bacterial colonisation. ImplantCast's MUTARS Silver Megaprosthesis System (implantcast GmBH, Buxtehude, Germany) uses a long-lasting silver modification to prevent bacterial attachment on surfaces not in direct contact with bone. After 28 d, roughly 30 % of the silver remains in the implant coating. Alternatively, by releasing a bolus of gentamicin within a few days of implantation, DePuy Synthes' Expert Tibial Nail PROtect hinders bacterial colonisation of the surface (Metsemakers et al., 2015) . These two clinical systems, used for different indications, have vastly different antimicrobial release profiles, which prompts the following questions: 1) which release profile is correct?; 2) is it dependent on anatomical location or injury type?; 3) is it dependent on the antimicrobial mechanism of action? The present study provided an understanding of the rate of bacterial colonisation of a titanium implant in the context of host cell adhesion. It gave a relevant timeline for further implant technologies seeking to reduce bacterial colonisation. By addressing the "race for the surface" in this manner, information regarding the temporal relationship between implant placement and infection susceptibility were presented. After a week in situ, the titanium was less prone to bacterial colonisation than groups that received a bacterial challenge immediately after surgery. This is potentially related to the significant proportion of monocytic/macrophagic host cells found on the titanium surface 7 d post-implantation. Finally, surface modifications or release of antibiotics or antimicrobials may reduce or delay the host integration with the implant, making the protective therapy less effective. This is a topic that needs to be further studied.
Importantly, the study revealed subtle differences in fluorescent and luminescent variants of S. aureus as compared to their UAMS-1 parental wildtype. This impacts the often-interchangeable use of reporters. Firstly, there were obvious health, weight and mortality changes when UAMS-1 was transduced with a GFP plasmid. These changes could be associated with changes in virulence caused by the transduction. For example, Salmonella expresses reduced pathogenic island genes and infectivity in bacteria containing the fluorescent plasmid (Knodler et al., 2005) . There were changes in the expression of some virulence regulators and markers of UAMS-1GFP, however, the mechanism for these virulence expression changes is unknown and beyond the scope of the present study.
The study did have limitations, as a rodent model may not directly correlate to clinical observations. Besides differences that may occur between species, anatomic location, injury severity and presence of comorbidities may also affect timeline and results. The presence of a fracture, for example, would exacerbate an infection and the inflammatory response (Morley et al., 2008; Shiels et al., 2018a) . Both unstable fractures and fractures stabilised with implantable hardware are at increased risk of infection and, as such, further investigation of the role of fracture in the "race for the surface" is needed (Merritt and Dowd, 1987) . Additionally, the present study did not investigate the role of blood supply in the rate of bacterial colonisation. It is possible that the change in blood flow to the area following IMN insertion increases the likelihood of colonisation. Schemitsch et al. (1994) identified a decrease in cortical blood perfusion when a sheep tibia was reamed and an intramedullary nail placed. A reamed tibia and nail placement required more time for normal blood flow to return as compared to an unreamed nail placement. Similarly, Brinker et al. (1999) measured 0 mL blood/ min in a reamed and nailed dog tibia immediately following procedure. Within the recovery time, blood flow in the reamed tibia never returned to normal, indicating that, with the concomitant reaming and IMN placement in the present study model, blood flow was decreased to the area, therefore preventing more bacterial access. In light of this assumption, the described approach not only illustrated the interplay between host attachment and infection but also described the time line in which it occurred. www.ecmjournal.org There is evidence that the types of cells that initially attach to implants remains conserved across species, from rodent to non-human primates (Hotchkiss et al., 2019; Veiseh et al., 2015) . It is worth noting that in vitro cellular differentiation of both rodent and human haematopoietic precursors occurs on similar time frames, differentiating within 3 d following stimulation, as also seen in the present in vivo study (Alfarsi et al., 2014; Gupta et al., 2014; Makihira et al., 2007) . Additionally, the study was limited to titanium implants, one of the most common materials used for orthopaedic devices. Although different materials can cause various host responses, there is evidence that these material-based differences are lost when challenged with bacteria (Rochford, 2019) . Finally, while the present study attempted to establish a temporal link between a delay in the introduction of bacteria and increased protection of an implant surface due to host colonisation, it is important to emphasise that the present model was contrived. Other means of host protection, such as deposition of fibrin or vasculature, may provide competitive inhibition for bacterial colonisation. Additionally, other means could have been used to synthesise a bacterial invasion without the use of virulent bacteria, heat-killed for example, which could provide information regarding host-cell colonisation in the presence of inflammation. However, the present study was intended to provide a potential time frame for implant protection strategies, i.e. antimicrobial coatings, based on an observed temporal pattern of host or bacterial colonisation and required further investigation and not intended to justify implant placement timing or the use of antimicrobials. Future investigations will allow elucidation of the changes induced to temporal patterns of colonisation in the presence of comorbidities, fractures, bacteria, bacterial components and antimicrobial agents. In summary, the dynamics of the initial colonising cells, differentiation in situ and time to differentiate into mature immune cells appears similar in various pre-clinical models (Sennerby et al., 1993; Veiseh et al., 2015) . This evidence suggests that the observed time frame needed for host immunoprotection of an implant may be clinically relevant and can serve as a blueprint for material strategies for implant protection and early integration.
Conclusion
The present study not only detected a time-dependent relationship between implant surgery and bacterial colonisation, it also observed an increase in local immune populations and their diversity that was associated with a decrease in bacterial colonisation. When bacteria were inoculated after 1 week, there were little to no bacteria on the implant despite the presence of bacteria within the bone tissue. Simultaneously, over 80 % of the haematopoietic cells on the surface of the IMN had differentiated into monocytes and macrophages. This information can give guidance to investigators for development of future devices and products that can thwart bacterial attachment or hasten host integration. A relatively short-time protection may only be needed, provided that the approach does not delay or impair host adhesion.
